American International Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-29,981
| Closed | -$4.53M | – | 3064 |
|
|
2022
Q3 | $4.53M | Buy |
29,981
+824
| +3% | +$125K | 0.03% | 710 |
|
|
2022
Q2 | $4.25M | Buy |
29,157
+1,504
| +5% | +$219K | 0.03% | 760 |
|
|
2022
Q1 | $3.28M | Sell |
27,653
-1,947
| -7% | -$231K | 0.02% | 891 |
|
|
2021
Q4 | $4.08M | Sell |
29,600
-885
| -3% | -$122K | 0.02% | 863 |
|
|
2021
Q3 | $4.24M | Buy |
30,485
+211
| +0.7% | +$29.3K | 0.02% | 835 |
|
|
2021
Q2 | $2.94K | Sell |
30,274
-479
| -2% | -$47 | 0.01% | 969 |
|
|
2021
Q1 | $2.1K | Sell |
30,753
-286
| -0.9% | -$20 | 0.01% | 1093 |
|
|
2020
Q4 | $2.66K | Buy |
31,039
+2,268
| +8% | +$194 | 0.01% | 976 |
|
|
2020
Q3 | $1.87M | Sell |
28,771
-85
| -0.3% | -$5.53K | 0.01% | 977 |
|
|
2020
Q2 | $2.11M | Buy |
28,856
+3,529
| +14% | +$258K | 0.01% | 943 |
|
|
2020
Q1 | $862K | Buy |
25,327
+836
| +3% | +$28.5K | ﹤0.01% | 1174 |
|
|
2019
Q4 | $1.33M | Sell |
24,491
-207
| -0.8% | -$11.3K | 0.01% | 1187 |
|
|
2019
Q3 | $1.03M | Buy |
24,698
+3,528
| +17% | +$147K | ﹤0.01% | 1275 |
|
|
2019
Q2 | $927K | Buy |
21,170
+1,248
| +6% | +$54.6K | ﹤0.01% | 1354 |
|
|
2019
Q1 | $1.03M | Buy |
19,922
+1,216
| +7% | +$62.6K | ﹤0.01% | 1303 |
|
|
2018
Q4 | $692K | Sell |
18,706
-143
| -0.8% | -$5.29K | ﹤0.01% | 1484 |
|
|
2018
Q3 | $708K | Buy |
18,849
+1,041
| +6% | +$39.1K | ﹤0.01% | 1674 |
|
|
2018
Q2 | $704K | Sell |
17,808
-2,495
| -12% | -$98.6K | ﹤0.01% | 1609 |
|
|
2018
Q1 | $523K | Buy |
20,303
+13,231
| +187% | +$341K | ﹤0.01% | 1693 |
|
|
2017
Q4 | $191K | Buy |
7,072
+366
| +5% | +$9.89K | ﹤0.01% | 2349 |
|
|
2017
Q3 | $251K | Buy |
6,706
+501
| +8% | +$18.8K | ﹤0.01% | 2159 |
|
|
2017
Q2 | $155K | Buy |
+6,205
| New | +$155K | ﹤0.01% | 2438 |
|